Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 12, 2017
Active Estrogen Receptor-alpha Signaling in Ovarian Cancer Models and Clinical SpecimensCourtney L Andersen, Matthew J Sikora, Michelle M Boisen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 15, 2020
The Capacity of the Ovarian Cancer Tumor Microenvironment to Integrate Inflammation Signaling Conveys a Shorter Disease-free IntervalKimberly R Jordan, Matthew J Sikora, Jill E Slansky, et al.
NPJ Breast Cancer|December 20, 2024
The EstroGene2.0 database for endocrine therapy response and resistance in breast cancerZheqi Li, Fangyuan Chen, Li Chen, et al.
Biorxiv : the Preprint Server for Biology|July 15, 2024
EstroGene2.0: A multi-omic database of response to estrogens, ER-modulators, and resistance to endocrine therapies in breast cancerZheqi Li, Fangyuan Chen, Li Chen, et al.
Biorxiv : the Preprint Server for Biology|December 16, 2024
Co-regulator activity of Mediator of DNA Damage Checkpoint 1 (MDC1) is associated with DNA repair dysfunction and PARP inhibitor sensitivity in lobular carcinoma of the breastJoseph L Sottnik, Madeleine T Shackleford, Camryn S Nesiba, et al.
Cancer Research|January 9, 2026
Altered MDC1 Interactions and Dysfunctional DNA Repair in Lobular Breast Cancer Confers Sensitivity to PARP InhibitionJoseph L Sottnik, Madeleine T Shackleford, Camryn S Nesiba, et al.
Biorxiv : the Preprint Server for Biology|October 28, 2024
Glutamate Transport Proteins and Metabolic Enzymes are Poor Prognostic Factors in Invasive Lobular CarcinomaTodd A Young, Shaymaa Bahnassy, Theresa C Abalum, et al.
NPJ Breast Cancer|July 3, 2019
FGFR4 overexpression and hotspot mutations in metastatic ER+ breast cancer are enriched in the lobular subtypeKevin M Levine, Nolan Priedigkeit, Ahmed Basudan, et al.
NPJ Breast Cancer|July 20, 2024
International survey on invasive lobular breast cancer identifies priority research questionsSteffi Oesterreich, Leigh Pate, Adrian V Lee, et al.
Nature Communications|December 2, 2017
Discovery of naturally occurring ESR1 mutations in breast cancer cell lines modelling endocrine resistanceLesley-Ann Martin, Ricardo Ribas, Nikiana Simigdala, et al.
Pageof 5